Patents-Review.com
ClassID:

108827 ⎘

C12N5/12 - CPC Classification

Classification description:

Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Cells modified by introduction of foreign genetic material Fused cells, e.g. hybridomas

Sub-classes:
Recent Application in this class:
#1
20260109760
2026-04-23

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

 #2
20260092110
2026-04-02

ANTIBODY WHICH BINDS TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN

 #3
20260035457
2026-02-05

ANTI-NOTCH3 ANTIBODY

 #4
20250382371
2025-12-18

ANTIBODY OR FRAGMENT THEREOF THAT BINDS TO FCRL1

 #5
20250345366
2025-11-13

MYOBLAST CHIMERIC CELLS (MCCs)

 #6
20250289884
2025-09-18

ANTI-NOTCH3 ANTIBODIES

 #7
20250154245
2025-05-15

MONOCLONAL ANTI-IL-1RACP ANTIBODIES

 #8
20250129167
2025-04-24

DUAL SPECIFICITY ANTIBODIES TO PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR

 #9
20250115879
2025-04-10

HYBRIDOMA CELL LINE SECRETING ANTI-POLYSTYRENE MONOCLONAL ANTIBODY AND USE THEREOF

 #10
20250026817
2025-01-23

Anti-Bed Bug Monoclonal Antibodies and Methods of Making and Uses Thereof

 #11
20240425600
2024-12-26

TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES

 #12
20240425599
2024-12-26

TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES

 #13
20240360245
2024-10-31

ANTI-GARP ANTIBODY

 #14
20240190954
2024-06-13

ANTIBODY FOR BINDING TO INTERLEUKIN 4 RECEPTOR

 #15
20240167006
2024-05-23

HIGH PRODUCTION OF RECOMBINANT PROTEIN BY MAKING CELL HYBRIDS AND ENRICHING FOR A PREFERRED MITOCHONDRIAL PHENOTYPE

 #16
20240156071
2024-05-16

ENHANCED IMMUNOGLOBULIN DIVERSITY

 #17
20240124577
2024-04-18

Antibody which binds to myelin oligodendrocyte glycoprotein

 #18
20240092932
2024-03-21

MONOCLONAL IGM ANTIBODIES FROM ENTIRELY CARBOHYDRATE CONSTRUCTS

 #19
20240026017
2024-01-25

ANTI-HUMAN CCR1 MONOCLONAL ANTIBODY

 #20
20230399622
2023-12-14

THERAPY FOR DEGENERATIVE DISEASE AND TISSUE DAMAGE

 #21
20230160883
2023-05-25

Tomato Zonate Spot Virus Detection Reagent

 #22
20230110712
2023-04-13

System and method for characterizing protein dimerization

 #23
20220347202
2022-11-03

Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent

 #24
20220235127
2022-07-28

ANTI-NOTCH3 ANTIBODY

 #25
20220195034
2022-06-23

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

 #26
20220169718
2022-06-02

Monoclonal anti-IL-1RAcP antibodies

 #27
20220160783
2022-05-26

MYOBLAST CHIMERIC CELLS (MCCs)

 #28
20220040216
2022-02-10

Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent

 #29
20220025044
2022-01-27

ANTIBODY WHICH BINDS TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN

 #30
20220010026
2022-01-13

Anti-GARP antibody

 #31
20210363249
2021-11-25

SIGLEC NEUTRALIZING ANTIBODIES

 #32
20210340252
2021-11-04

ANTI-TIM-3 ANTIBODIES AND USES THEREOF

 #33
20210322570
2021-10-21

Gene and cell therapy using cell fusion technology

 #34
20210292378
2021-09-23

ENHANCED PRODUCTION OF IMMUNOGLOBULINS

 #35
20210238282
2021-08-05

Antibody against TIM-3 and application thereof

 #36
20210214445
2021-07-15

Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor

 #37
20210171627
2021-06-10

Anti-notch3 antibodies

 #38
20210162045
2021-06-03

Human endothelin receptor antibody and use thereof

 #39
20210079088
2021-03-18

Antibody for binding to interleukin 4 receptor

 #40
20210051929
2021-02-25

GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF

 #41
20210000089
2021-01-07

Enhanced immunoglobulin diversity

 #42
20200407438
2020-12-31

Monoclonal anti-IL-1RAcp antibodies

 #43
20200363405
2020-11-19

Anti-bed bug monoclonal antibodies and methods of making and uses thereof

 #44
20200355686
2020-11-12

MONOCLONAL ANTIBODY FOR PREDICTING TAMOXIFEN RESPONSE IN BREAST CANCER PATIENTS

 #45
20200326347
2020-10-15

Antibody specifically binding to bovine pregnancy-associated glycoprotein 1 and use thereof

 #46
20200323997
2020-10-15

Gene and cell therapy using cell fusion technology

 #47
20200309768
2020-10-01

System and method for characterizing protein dimerization

 #48
20200299397
2020-09-24

Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-Synuclein

 #49
20200255514
2020-08-13

Antibody for binding to interleukin 4 receptor

 #50
20200239850
2020-07-30

MAMMALIAN CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA

 #51
20200199240
2020-06-25

Anti-human CCR1 monoclonal antibody

 #52
20200148778
2020-05-14

Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof

 #53
20200071398
2020-03-05

Anti-LILRB3 antibodies and methods of use thereof

 #54
20200040106
2020-02-06

Hybridoma cell line of secreting meloxicam monoclonal antibodies and application thereof

 #55
20190365894
2019-12-05

Human endothelin receptor antibody and use thereof

 #56
20190352397
2019-11-21

Antibody which binds to myelin oligodendrocyte glycoprotein

 #57
20190345255
2019-11-14

MONOCLONAL IGM ANTIBODIES FROM ENTIRELY CARBOHYDRATE CONSTRUCTS

 #58
20190345230
2019-11-14

Broad-spectrum monoclonal anti-flu B antibody and uses thereof

 #59
20190338026
2019-11-07

Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

 #60
20190330595
2019-10-31

Mammalian cells enriched with functional mitochondria

 #61
20190322732
2019-10-24

Antibody inhibiting binding of VEGF to NRP1

 #62
20190292263
2019-09-26

GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF

 #63
20190292241
2019-09-26

GDF15 fusion proteins and uses thereof

 #64
20190284304
2019-09-19

Hybridoma cell line of secreting clarithromycin monoclonal antibodies and preparation method thereof

 #65
20190284275
2019-09-19

Anti-KRAS binding proteins

 #66
20190256609
2019-08-22

Monoclonal antibodies prevent cell surface protein shedding and block tumor growth

 #67
20190242877
2019-08-08

System and method for characterizing protein dimerization

 #68
20190234959
2019-08-01

SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES

 #69
20190185568
2019-06-20

ANTI-PD-1 ANTIBODY

 #70
20190177414
2019-06-13

Anti-CTLA4 antibodies

 #71
20190177408
2019-06-13

ANTIBODY FOR BINDING TO INTERLEUKIN 4 RECEPTOR

 #72
20190144537
2019-05-16

Anti-Notch3 antibody

 #73
20190117751
2019-04-25

TUMOR ANTIGEN PEPTIDE

 #74
20190106487
2019-04-11

Monoclonal anti-IL-1RAcP antibodies

 #75
20190106484
2019-04-11

ANTIBODY AGAINST PEPTIDE ENCODED BY EXON-21 OF PERIOSTIN AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION-ASSOCIATED DISEASES CONTAINING THE SAME

 #76
20190085077
2019-03-21

Siglec neutralizing antibodies

 #77
20190077867
2019-03-14

Anti-human PD-L1 humanized monoclonal antibody and application thereof

 #78
20190075769
2019-03-14

Hybrid dairy cattle and systems for maximizing hybrid advantage

 #79
20190075768
2019-03-14

Hybrid dairy cattle and systems for maximizing hybrid advantage

 #80
20190053474
2019-02-21

Enhanced immunoglobulin diversity

 #81
20190048090
2019-02-14

Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 RGD motif

 #82
20180327511
2018-11-15

Anti-garp antibody

 #83
20180292407
2018-10-11

Method for producing antigen specific monoclonal antibody

 #84
20180273625
2018-09-27

Antibody for immunoassay and method for preparing same

 #85
20180267040
2018-09-20

Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having active structure and monitoring of cancer treatment using such anti-REIC/Dkk-3 antibody

 #86
20180258184
2018-09-13

Anti-garp antibody

 #87
20180256714
2018-09-13

Human endothelin receptor antibody and use thereof

 #88
20180246107
2018-08-30

Monoclonal antibody for predicting tamoxifen response in breast cancer patients

 #89
20180230213
2018-08-16

Anti-NOTCH3 antibodies

 #90
20180224457
2018-08-09

Anti-pancreatic cancer monoclonal antibody and use thereof

 #91
20180193487
2018-07-12

Gene and cell therapy using cell fusion technology

 #92
20180179294
2018-06-28

TOLL-LIKE RECEPTOR 3 ANTAGONISTS

 #93
20180112005
2018-04-26

Polynucleotides encoding anti-Notch1 NRR antibody polypeptides

 #94
20180085398
2018-03-29

COMPOSITIONS AND METHODS OF TREATING CANCER

 #95
20180085350
2018-03-29

Compositions and methods of treating cancer

 #96
20180036344
2018-02-08

Targeted transplantation of mitochondria to hepatocytes

 #97
20180030413
2018-02-01

MAMMALIAN CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA

 #98
20170327560
2017-11-16

GDF15 fusion proteins and uses thereof

 #99
20170267782
2017-09-21

Protein assay method specific to TRACP-5b (tartrate resistant acid phosphatase 5b)

 #100
20170253668
2017-09-07

THERAPEUTIC AND DIAGNOSTIC ANTI-LOXL4 ANTIBODIES

 #101
20170226162
2017-08-10

Enhanced production of immunoglobulins

 #102
20170204369
2017-07-20

Nuclear transfer

 #103
20170174777
2017-06-22

Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein

 #104
20170137501
2017-05-18

Anti-bed bug monoclonal antibodies and methods of making and uses thereof

 #105
20170058041
2017-03-02

Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist

 #106
20160355602
2016-12-08

Bispecific antibody binding to human TLR2 and human TLR4

 #107
20160185852
2016-06-30

Anti-Notch3 antibodies

 #108
20160146840
2016-05-26

Augurin immunoassay

 #109
20160108109
2016-04-21

Antibody against peptide encoded by Exon-21 of periostin and pharmaceutical composition for preventing or treating inflammation-associated diseases containing the same

 #110
20150259409
2015-09-17

Anti-BLyS antibody

 #111
20150197563
2015-07-16

Method of treating cancer by administering a monoclonal antibody that binds human NOTCH2 and NOTCH3

 #112
20150183878
2015-07-02

Compositions and methods for diagnosing and treating cancer

 #113
20150166963
2015-06-18

Notch1 receptor binding agents and methods of use thereof

 #114
20140296442
2014-10-02

Antibacterial polymers and method for obtaining the same

 #115
20140093508
2014-04-03

Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists

 #116
20130345408
2013-12-26

Antibody against amyloid precursor protein signal peptide

 #117
20130323257
2013-12-05

Antibodies that bind the glutamate ligand binding region of NOTCH3

 #118
20130296536
2013-11-07

Monoclonal antibody that binds human notch2 and notch3

 #119
20130280277
2013-10-24

Notch1 receptor antibodies and methods of treatment

 #120
20130280263
2013-10-24

Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies

 #121
20130244281
2013-09-19

Polynucleotides encoding Toll-Like Receptor 3 antagonists

 #122
20130202607
2013-08-08

DNA encoding an anti-system ASC amino acid transporter 2 (ASCT2) antibody

 #123
20130052737
2013-02-28

Method for selective electrofusion of at least two fusion partners having cell-like membranes

 #124
20120308558
2012-12-06

Methods of using antibodies that bind the glutamate ligand binding region of Notch1

 #125
20120288496
2012-11-15

Methods of treatment by administering antibodies to notch receptors

 #126
20110311552
2011-12-22

NOTCH1 receptor antibodies and methods of treatment

 #127
20110008352
2011-01-13

Toll-like receptor 3 antagonists

 #128
20100196392
2010-08-05

Anti-system ASC amino acid transporter 2 (ASCT2) antibody

 #129
20100166778
2010-07-01

Toll-like receptor 3 antagonists

 #130
20100111958
2010-05-06

Antibodies to notch receptors

 #131
20100021996
2010-01-28

Genetically Altered Anti-body Producing Cell Lines With Improved Antibody Characteristics

 #132
20090264312
2009-10-22

METHOD FOR REMOVING DESIRED CHROMOSOME AND TAILOR-MADE MEDICAL TREATMENT UTILIZING THE SAME

 #133
20090258026
2009-10-15

ANTI-NOTCH1 NRR ANTIBODIES AND METHODS USING SAME

 #134
20090081238
2009-03-26

Anti-Notch1 NRR antibodies

 #135
20090047285
2009-02-19

Antibodies that bind the glutamate ligand binding region of Notch1

 #136
20050048621
2005-03-03

Genetically altered antibody-producing cell lines with improved antibody characteristics

 #137
16222792
2019-06-18

Hybridoma cell line of secreting clarithromycin monoclonal antibodies and preparation method thereof